The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

NCT02525198 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 259

Last updated 2024-05-14

No results posted yet for this study

Summary

There is a dearth of research which takes a multi-compound approach to dietary interventions, in humans, aimed at improving outcome measures of cognition. Animal research in particular points towards fatty acids and flavonoids having a potentiating effect on each other, and possibly even being synergistic. Thus, study products will be administered in the present trial comprising both of these compounds, with a view to investigating their potential effects on cognition in older adults with mild cognitive impairment (MCI) or subjective memory impairment (SMI).

Conditions

Interventions

DIETARY_SUPPLEMENT

fatty acid/flavonoid blend

see arm description

DIETARY_SUPPLEMENT

Placebo

see arm description

Sponsors & Collaborators

  • Swinburne University of Technology

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • University of East Anglia

    lead OTHER

Principal Investigators

  • Anne Marie Minihane, PhD · Department of Nutrition, University of East Anglia, Norwich, U.K.

  • Andrew Scholey, PhD · Centre for Human Psychopharmacology, Swinburne University of Technology

  • Neal J Cohen, PhD · Beckman Institute, University of Illinois

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States
  • Australia
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02525198 on ClinicalTrials.gov